`
`In Re:
`
`US. Patent of"Marks el al.
`
`Proceeding N0.:
`
`IPR2016-01479
`
`Patent No.:
`
`9,006,224
`
`Application No.:
`
`12/094,173
`
`For:
`
`NEUROEND'O'CRINE TUMORTREATMENT
`
`PATENT OWNER’S POWER OF ATTORNEY IN .AN INTER PAR TES REVIEW
`
`Patent Owner Novartis Pharmacieuticals Corporation (“N'ova'rtis”) hereby appoints
`
`Nicholas N. Kallas (Reg. No. 31,530), Laura K. Fishwick (Reg. No. 69,907), Peter I. Waibel
`
`(Reg. No. 43,228), and Gregory D. Ferraro (Reg, No. 36,134) as its attorneys to prosecute the
`
`aforementioned proceeding and totransact all business in the United States Patentand
`
`Trademark Office connected therewith.
`
`Please address all correspondence as follows:
`
`Nicholas N. Kallas
`
`Fitzpatrick, Cella, Harper &. Scinto
`1290 Avenue of the Americas
`
`New York, NY 10104-3800
`Telephone: (212) 218-2100
`Facsimile: (212) 218-2200
`nkallas@fchs.com
`
`
`
`Novartis- Pharmaceuticals Corporation
`One Health Plaza
`
`' ovartis Pharmaceuticals Corporation
`OneHea'lth Plaza
`
`East Hanover, NJ 07936-1080
`
`East HanoVer, NJ 07936-1080.
`
`Witnessed by:
`
`Witnessed by:
`
`Signature
`tail
`
`Printed name
`
`:1
`
`Signa
`
`e
`
`ififil
`(if/5
`if
`1
`Printed name.
`
`